These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9111131)

  • 1. College of American Pathologists Conference XXX on quality and liability issues with the Papanicolaou smear: summation.
    Austin RM
    Arch Pathol Lab Med; 1997 Mar; 121(3):341-2. PubMed ID: 9111131
    [No Abstract]   [Full Text] [Related]  

  • 2. College of American Pathologists Conference XXX on quality and liability issues with the Papanicolaou smear: introduction.
    Austin RM
    Arch Pathol Lab Med; 1997 Mar; 121(3):227-8. PubMed ID: 9111105
    [No Abstract]   [Full Text] [Related]  

  • 3. Liability issues with the Papanicolaou smear: general legal background.
    Kline TJ
    Arch Pathol Lab Med; 1997 Mar; 121(3):250-2. PubMed ID: 9111110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expert review of histologic slides and Papanicolaou tests in the context of litigation or potential litigation. Surgical Pathology Committee and Cytopathology Committee of the College of American Pathologists.
    Fitzgibbons PL; Austin RM
    Arch Pathol Lab Med; 2000 Nov; 124(11):1717-9. PubMed ID: 11079035
    [No Abstract]   [Full Text] [Related]  

  • 5. Pap smear liability: do computer-assisted rescreening devices affect the standard of care?
    Bierig JR; Weber SA
    CAP Today; 1997 Apr; 11(4):32-4. PubMed ID: 10174223
    [No Abstract]   [Full Text] [Related]  

  • 6. Quality assurance activities of the College of American Pathologists.
    Kraemer BB
    Acta Cytol; 1989; 33(4):434-8. PubMed ID: 2750430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality and liability issues with the Papanicolaou smear: the role of professional organizations in reform initiatives.
    Stanley MW
    Arch Pathol Lab Med; 1997 Mar; 121(3):321-6. PubMed ID: 9111127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liability issues with the Papanicolaou smear: a defense lawyer's perspective.
    Varner CD
    Arch Pathol Lab Med; 1997 Mar; 121(3):315-20. PubMed ID: 9111126
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality assurance in cytopathology. Recommendations and ongoing quality assurance activities of the American Society of Clinical Pathologists.
    Bonfiglio TA
    Acta Cytol; 1989; 33(4):431-3. PubMed ID: 2750429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality and liability issues with the Papanicolaou smear: lessons from the science of error prevention.
    Derman H
    Arch Pathol Lab Med; 1997 Mar; 121(3):287-91. PubMed ID: 9111120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Education and training for cytopathologists. Its role in quality assurance.
    Parker JE
    Acta Cytol; 1989; 33(4):448-50. PubMed ID: 2750433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gynecologist's perspective of liability and quality issues with the Papanicolaou smear.
    Greer BE
    Arch Pathol Lab Med; 1997 Mar; 121(3):246-9. PubMed ID: 9111109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bethesda System reporting rates for conventional Papanicolaou tests and liquid-based cytology in a large Chinese, College of American Pathologists-certified independent medical laboratory: analysis of 1394389 Papanicolaou test reports.
    Zheng B; Austin RM; Liang X; Li Z; Chen C; Yan S; Zhao C
    Arch Pathol Lab Med; 2015 Mar; 139(3):373-7. PubMed ID: 25724034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unsatisfactory reporting rates: 2006 practices of participants in the college of american pathologists interlaboratory comparison program in gynecologic cytology.
    Moriarty AT; Clayton AC; Zaleski S; Henry MR; Schwartz MR; Eversole GM; Tench WD; Fatheree LA; Souers RJ; Wilbur DC
    Arch Pathol Lab Med; 2009 Dec; 133(12):1912-6. PubMed ID: 19961244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American Society of Cytopathology Laboratory Accreditation Program.
    Gupta PK; Erozan YS; Schwartz MR
    Arch Pathol Lab Med; 1997 Mar; 121(3):260-3. PubMed ID: 9111113
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytopathology laboratory improvement programs of the College of American Pathologists: Laboratory Accreditation Program (CAP LAP) and Performance Improvement Program in Cervicovaginal Cytology (CAP PAP).
    Nielsen ML
    Arch Pathol Lab Med; 1997 Mar; 121(3):256-9. PubMed ID: 9111112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papanicolaou smear 5-year retrospective review: what is required by the Clinical Laboratory Improvement Amendments of 1988?
    Davey DD
    Arch Pathol Lab Med; 1997 Mar; 121(3):296-8. PubMed ID: 9111122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for reducing Papanicolaou smear screening errors: principles derived from data and experience with quality control.
    Krieger PA
    Arch Pathol Lab Med; 1997 Mar; 121(3):277-81. PubMed ID: 9111118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality improvement opportunities in gynecologic cytologic-histologic correlations: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 4.
    Crothers BA; Jones BA; Cahill LA; Moriarty AT; Mody DR; Tench WD; Souers RJ
    Arch Pathol Lab Med; 2013 Feb; 137(2):199-213. PubMed ID: 23368862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Pap smear, automated rescreening, and negligent nondisclosure.
    Godfrey SE
    Am J Clin Pathol; 1999 Jan; 111(1):14-7. PubMed ID: 9894449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.